|
Match
|
Document |
Document Title |
|
|
7612141 |
Hair cleansing composition
Provided is a hair cleansing composition comprising (A) an amphipathic amide lipid, (B) an anionic surfactant and (C) a silicone. The hair cleansing composition of the present invention has...
|
|
|
7592373 |
Amide compounds with MCH antagonistic activity and medicaments comprising these compounds
Compounds of formula (I)
wherein A, B, b, W, X, Y, Z, R 1 , R 2 , and R 3 have the meanings given in claim 1 , pharmaceutical compositions these compounds, and methods of preventing or...
|
|
|
7592365 |
Substituted pyrroles, compositions containing same, method for making same and use thereof
The disclosure concerns substituted pyrroles of formula (I):
wherein A, L, Ar, R1, R2, R5, and Ra are as defined in the disclosure, compositions containing the same, methods for making the same...
|
|
|
7582306 |
Pseudoceramides and cosmetic compositions comprising the same
The present invention relates to a pseudoceramide represented by the following formula (I) and a cosmetic composition comprising the same:
wherein Z represents —OH and Y represents...
|
|
|
7579379 |
CETP activity inhibitors
The present invention provides a CETP activity inhibitor comprising as an active ingredient a compound represented by the formula (I):
wherein R represents a straight chain or branched alkyl...
|
|
|
7576103 |
Tetralin and indane derivatives and uses thereof
Compounds of the formula I:
or pharmaceutically acceptable salts thereof,
wherein m, p, q, Ar, R 1 and R 2 are as defined herein. Also provided are methods for preparing, compositions...
|
|
|
7550490 |
Benzamide derivatives as histone deacetylase inhibitors with potent differentiation and anti-proliferation activity
The present invention is related to the preparation and pharmaceutical use of novel benzamide derivatives as defined in the specification of formula (I) as histone deacetylase inhibitors (HDACI),...
|
|
|
7538141 |
Compounds for the treatment of diseases
The invention relates to compounds of formula (1)
and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives....
|
|
|
7538081 |
Method and agent for enhancing diffusivity and long-lasting property of fragrance
A fragrance composition having an excellent diffusivity and long-lasting property of fragrance and a cosmetic, toiletry, bath composition, food and drink and pharmaceutical having an excellent...
|
|
|
7524885 |
Compounds that stimulate glucose utilization and methods of use
The invention provides novel compounds of the Formula (I) that stimulate rates of glucose oxidation in myocardial cells:
wherein W, Cyc, p, Y, X, Z, R, R 1 , R 2 , R 3 , R 4 , I, m and n...
|
|
|
7517913 |
Polyamine conjugates with acidic retinoids and preparation thereof
Invented are novel polyamine conjugates which have been readily obtained using as key-step the condensation of linear, conformationally restricted, cyclic and branched polyamines or suitably...
|
|
|
7485315 |
Compositions comprising a compound of low solubility and a lipophilic amino acid derivative, uses thereof and process for dissolving a compound of low solubility
The invention relates to a process for dissolving at least one compound of low solubility in water, the said process comprising the essential step of mixing the compound of low solubility with at...
|
|
|
7482378 |
Physiological cooling compositions
The present invention provides, in one aspect, a physiological cooling composition comprising at least one cyclohexane carboxamide, at least one acyclic carboxamide, and at least one stereoisomer...
|
|
|
7482160 |
Process of making a compound by forming a polymer from a template drug
A method of forming polymers in the presence of nucleic acid using template polymerization. These methods can be used for the delivery of nucleic acids, for condensing the nucleic acid, for forming...
|
|
|
7465754 |
Method of potentiating chemotherapy and treating solid tumors
This invention provides a method of treating solid tumors which comprises administering an effective amount of a combination of (1) a bioresponse modifier and (2) a chemotherapeutic agent. This...
|
|
|
7449315 |
Bifunctional energy-reversible acyl-compositions
Energy-reversible acyl conjugates, intermediates, and related compositions are disclosed. In preferred aspects, examples of such compositions include:
|
|
|
7439394 |
Cyclohexyl-1,4-diamine compounds
Novel cyclohexyl-1,4-diamine compounds corresponding to formula I,
processes for the production thereof, pharmaceutical compositions containing these compounds, methods of producing...
|
|
|
7435851 |
Puleganic amides
The present invention provides substituted puleganic amides and compositions thereof, which are both useful as a topical treatment for skin, such as a repellant for insects and arthropods.
|
|
|
7432307 |
Modulators of retinol-retinol binding protein (RBP)-transthyretin (TTR) complex formation
Described herein are methods and compositions for the detection of transthyretin (TTR), retinol binding protein (RBP) and retinol complex formation. The methods and compositions described herein...
|
|
|
7429618 |
Potassium channel modulators
This invention relates to novel compounds useful as potassium channel modulators. More specifically the invention provides chemical compounds useful as modulators of SK Ca and/or IK Ca channels.
|
|
|
7425578 |
Immunoregulatory compounds and derivatives and methods of treating diseases therewith
Compounds are disclosed having the structure of Formula I:
where R 1 , R 3 , and R 4 are independently hydrogen or C 1 to C 4 alkyl, and R 2 is:
where R 5 is selected from the group...
|
|
|
7423177 |
Carboxamide derivatives as therapeutic agents
This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of...
|
|
|
7414152 |
N-substituted p-menthane carboxamides
Cooling compounds are provided having the formula:
wherein, m is 0 or 1, Y and Z are selected independently from the group consisting of H, OH, C1-C4 straight or branched alkyl, and a C1-C4...
|
|
|
7388029 |
Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
A method for treating hair loss in mammals uses compositions containing prostaglandin F analogs. The compositions can be applied topically to the skin. The compositions can arrest hair loss,...
|
|
|
7368478 |
Methods for inhibiting angiogenesis and tumor growth
Angiogenesis, tumor growth, and metalloproteinase 2 (MMP2) interaction with integrin-α v β 3 are inhibited by an inhibitor compound of formula:
wherein G 1 and G 2 are each independently...
|
|
|
7361688 |
Substituted aminoalcohols useful in treatment of Alzheimer's disease
The invention provides compounds of formula (I): useful in treating Alzheimer's disease and other similar diseases. These compounds include inhibitors of the beta-secretase enzyme that are useful...
|
|
|
7348353 |
Acetylene derivatives having mGluR 5 antagonistic activity
The invention provides compounds of formula (I) wherein m, n, A, R, R′, R″, R 0 , X and Y are as defined in the description, and their preparation. The compounds of formula (I) are useful as...
|
|
|
7326732 |
EP2 receptor agonists
A compound of formula (I):
or a salt, solvate and chemically protected form thereof, wherein:
R 5 is an optionally substituted C 5-20 aryl or C 4-20 alkyl group; A is selected from...
|
|
|
7294643 |
UK-1 analogues: methods of preparation and use
The present invention includes a number of structural analogues of UK-1. A comparision of the anticancer activity of the UK-1 analogues with their ability to inhibit the growth of...
|
|
|
7288262 |
Composition comprising a cyclohexane-based compound, compound and use of said compound to structure a composition
Compositions, in particular cosmetic compositions, comprising a cyclohexane-based compound defined by formula (I):
wherein:
R, which may be identical or different, are each chosen from...
|
|
|
7271196 |
CETP activity inhibitors
The present invention provides a CETP activity inhibitor comprising as an active ingredient a compound represented by the formula (I):
wherein R represents a straight chain or branched alkyl...
|
|
|
7253210 |
Methylene-bridged selective androgen receptor modulators and methods of use thereof
This invention provides a class of androgen receptor targeting agents (ARTA). The agents define a new subclass of compounds, which are selective androgen receptor modulators (SARM). Several of the...
|
|
|
7244751 |
Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
The present invention is related to the preparation and pharmaceutical use of novel benzamide derivatives as defined in the specification of formula (I) as histone deacetylase inhibitors (HDACI),...
|
|
|
7241802 |
Substituted cyclohexylcarboxylic acid amide compounds
Substituted cyclohexylcarboxylic acid amide compounds, processes for their production, pharmaceutical compositions containing these compounds and the use of substituted cyclohexylcarboxylic acid...
|
|
|
7223746 |
Omega cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists
The invention relates to the use of derivatives of E-type prostaglandins as EP 2 agonists, in general, and, in particular as ocular hypotensives. The PGE derivatives used in accordance with the...
|
|
|
7192983 |
N-protected/N-substituted-beta-amino hydroxy sulfonates
N-protected/N-substituted alpha-amino aldehydes, which are useful as pharmaceuticals and pharmaceutical intermediates, can be stored and shipped in a more stable form as...
|
|
|
7179455 |
Pesticide in gel form
The invention relates to a bait matrix which includes a gelling agent and a pesticide. The bait matrix is useful for controlling pests by attracting and poisoning them. The gel matrix is...
|
|
|
7173063 |
Topoisomerase poisons for the treatment of proliferative disorders
Methods for the treatment of a proliferative disorder are provided in which a subject in need of such treatment is administered an effective amount of a compound selected from: compounds of formula...
|
|
|
7160922 |
Hemihydrate of a selective functional M1 muscarine receptor agonist
The present invention provides crystalline biphenyl-4-carboxylic acid (R)-(6-(1-((4-fluorobenzyl)methylamino)ethylideneamino)-2(R)
-hydroxyindan-1-yl)amide hemihydrate, compositions thereof,...
|
|
|
7151117 |
Concentrated X-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions
The present application is directed to the use of X-ray contrast media that act as universal antigens that are labeled herein as “pseudoantigens.” X-ray contrast media have the potential to...
|
|
|
7151095 |
Immunoregulatory compounds and derivatives and methods of treating diseases therewith
Compounds are disclosed having the structure of Formula I:
where R 1 , R 3 , and R 4 are independently hydrogen or C 1 to C 4 alkyl, and R 2 is:
where R 5 is selected from the group...
|
|
|
7132454 |
HEXIM1 as a suppressor of HIV replication and cardiac hypertrophy
Cellular transcription is modulated by increasing or decreasing the amount of active HEXIM1 in the cell. The methods are applied to the treatment of HIV infection and cardiac hypertrophy. Assays...
|
|
|
7119120 |
Phosphate transport inhibitors
Disclosed are compounds which have been identified as inhibitors of phosphate transport. Many of the compounds are represented by Structural Formula (I):
|
|
|
7115660 |
Methods for inhibiting angiogenesis and tumor growth
Angiogenesis, tumor growth, and metalloproteinase 2 (MMP2) interaction with integrin-α v β 3 are inhibited by an inhibitor compound of formula (I): wherein G 1 and G 2 are each independently...
|
|
|
7108867 |
Process for preparing particles
A process for preparing particles of a substance, such as a protein or polypeptide, comprising: (a) preparing a first liquid comprising water, the substance and a modulator, wherein the modulator...
|
|
|
7105539 |
Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex
The present invention relates to derivatives of succinic and glutaric acids and analogues thereof, having the following general formula:
useful as inhibitors of PHEX. These derivatives are...
|
|
|
7101895 |
Cyclohexyl sulphone derivatives as gamma-secretase inhibitors
Compounds of formula I:
wherein Ar 1 and Ar 2 are optionally substituted aryl or heteroaryl, L is a bond, ═CH— or —(CHR a ) n —, and X is SCN, SR 1 , S(O)R 1 , (CR a R b ) m SO 2 R 1...
|
|
|
7074833 |
Use of the (1S,2R) enantiomer of milnacipran for the preparation of a drug
A method for treating or preventing a disorder or a condition by double inhibition of serotonin (5-HT) and noradrenaline (NA) reuptake in a subject in need thereof, while limiting the risks of...
|
|
|
7074780 |
Substituted phenylcyclohexanecarboxamides and their use
The present invention relates to substituted phenylcyclohexanecarboxamides of the formula (I)
to processes for their preparation and to their use in medicaments, in particular for the...
|
|
|
7049317 |
CCR-3 receptor antagonists
The invention provides compounds of Formula (I):
wherein R 1 –R 4 have any of the values defined in the specification that are CCR-3 receptor antagonists, pharmaceutical compositions...
|